Unified Magnifying Endoscopic Classification (UMEC) of Gastrointestinal Lesions: A North American Validation Study
Open Access
- 9 December 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of the Canadian Association of Gastroenterology
- Vol. 7 (3) , 246-254
Abstract
Background and study aim: Magnifying endoscopy enables the diagnosis of advanced neoplasia throughout the gastrointestinal tract. The unified magnifying endoscopic classification (UMEC) framework unifies optical diagnosis criteria in the esophagus, stomach, and colon, dividing lesions into three categories: non-neoplastic, intramucosal neoplasia, and deep submucosal invasive cancer. This study aims to ascertain the performance of North American endoscopists when using the UMEC. Methods: In this retrospective cohort study, five North American endoscopists without prior training in magnifying endoscopy independently diagnosed images of gastrointestinal tract lesions using UMEC. All endoscopists were blinded to endoscopic findings and histopathological diagnosis. Using histopathology as the gold standard, the endoscopists’ diagnostic performances using UMEC were evaluated. Results: A total of 299 lesions (77 esophagus, 92 stomach, and 130 colon) were assessed. For esophageal squamous cell carcinoma, the sensitivity, specificity, and accuracy ranged from 65.2% (95%CI: 50.9–77.9) to 87.0% (95%CI: 75.3–94.6), 77.4% (95%CI: 60.9–89.6) to 96.8% (95%CI: 86.8–99.8), and 75.3% to 87.0%, respectively. For gastric adenocarcinoma, the sensitivity, specificity, and accuracy ranged from 94.9% (95%CI: 85.0–99.1) to 100%, 52.9% (95%CI: 39.4–66.2) to 92.2% (95%CI: 82.7–97.5), and 73.3% to 93.3%. For colorectal adenocarcinoma, the sensitivity, specificity, and accuracy ranged from 76.2% (95%CI: 62.0–87.3) to 83.3% (95%CI: 70.3–92.5), 89.7% (95%CI: 82.1–94.9) to 97.7% (95%CI: 93.1–99.6), and 86.8% to 90.7%. Intraclass correlation coefficients indicated good to excellent reliability. Conclusion: UMEC is a simple classification that may be used to introduce endoscopists to magnifying narrow-band imaging and optical diagnosis, yielding satisfactory diagnostic accuracy.Keywords
Funding Information
- AbbVie
This publication has 30 references indexed in Scilit:
- Magnifying Narrow Band Imaging (NBI) for the Diagnosis of Localized Colorectal Lesions Using the Japan NBI Expert Team (JNET) ClassificationOncology, 2017
- Diagnostic performance of Japan NBI Expert Team classification for differentiation among noninvasive, superficially invasive, and deeply invasive colorectal neoplasiaGastrointestinal Endoscopy, 2017
- Clinical impact and characteristics of the narrow-band imaging magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert TeamGastrointestinal Endoscopy, 2017
- Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal SocietyEsophagus, 2016
- Endoscopic optical diagnosis provides high diagnostic accuracy of esophageal squamous cell carcinomaBMC Gastroenterology, 2014
- Endoscopic prediction of deep submucosal invasive carcinoma: validation of the Narrow-Band Imaging International Colorectal Endoscopic (NICE) classificationGastrointestinal Endoscopy, 2013
- Validation of a Simple Classification System for Endoscopic Diagnosis of Small Colorectal Polyps Using Narrow-Band ImagingGastroenterology, 2012
- Prediction of invasion depth for submucosal differentiated gastric cancer by magnifying endoscopy with narrow-band imagingOncology Reports, 2012
- Endoscopy in screening for digestive cancerWorld Journal of Gastrointestinal Endoscopy, 2012
- Meshed capillary vessels found on narrow-band imaging without optical magnification effectively identifies colorectal neoplasia: a North American validation of the Japanese experienceGastrointestinal Endoscopy, 2010